Buy One Get One free -Llimited Time Offer X
Arvast CF Capsule DR is a commercial drug that is prescribed in the form of Capsule. Secondary and off-label uses of Arvast CF Capsule DR have also been mentioned below.
The optimal dosage of Arvast CF Capsule DR is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Arvast CF Capsule DR include Nausea or vomiting, Headache, Constipation. Some other side effects of Arvast CF Capsule DR have been listed ahead. Such side effects of Arvast CF Capsule DR normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Arvast CF Capsule DR has a Moderate effect for pregnant women and Moderate effect on lactating mothers. In addition, Arvast CF Capsule DR's effects on the liver, heart and kidney are discussed below in the Arvast CF Capsule DR related warnings section.
Individuals suffering from medical conditions like Diabetes must refrain from the use of Arvast CF Capsule DR since this can cause severe adverse effects.
Besides this, Arvast CF Capsule DR may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Arvast CF Capsule DR is considered not safe while driving, and is not addictive.
Arvast CF Capsule DR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Arvast CF Capsule DR safe for pregnant women?
Pregnant women may experience moderate side effects from Arvast CF. It is best to stop taking Arvast CF immediately and inform your doctor if you notice any discomfort.
Is the use of Arvast CF Capsule DR safe during breastfeeding?
Breastfeeding women may feel side effects of Arvast CF. If you see any side effects, stop taking Arvast CF immediately and talk to your doctor. Take Arvast CF again, only after your doctor's advice.
What is the effect of Arvast CF Capsule DR on the Kidneys?
Very few cases of side effects of Arvast CF on kidney have been reported.
What is the effect of Arvast CF Capsule DR on the Liver?
Very few cases of side effects of Arvast CF on the liver have been reported.
What is the effect of Arvast CF Capsule DR on the Heart?
There may be an adverse effect on the heart after taking Arvast CF. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Arvast CF Capsule DR unless your doctor advises you to do so -
Is this Arvast CF Capsule DR habit forming or addictive?
Arvast CF Capsule DR is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Arvast CF Capsule DR you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Arvast CF Capsule DR should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Arvast CF Capsule DR for mental disorders.
Interaction between Food and Arvast CF Capsule DR
There isn't any research available on the side effects of taking Arvast CF Capsule DR with food.
Interaction between Alcohol and Arvast CF Capsule DR
No research has been done on this till date. Therefore, it is not known what the effect of taking Arvast CF Capsule DR with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650